During the past decade, NZOZ Magodent - Centrum Medczyne Ostrobramska conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "NZOZ Magodent - Centrum Medczyne Ostrobramska" #1 collaborator was "Parexel" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "NZOZ Magodent - Centrum Medczyne Ostrobramska" are "Chemotherapy-Induced Nausea and Vomiting" (2 trials). Many other conditions were trialed in "NZOZ Magodent - Centrum Medczyne Ostrobramska" in a lesser frequency.

Most popular intervention types in "NZOZ Magodent - Centrum Medczyne Ostrobramska" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (2 trials), "I.V. palonosetron" (1 trials), "Netupitant and Palonosetron" (1 trials), "Oral palonosetron" (1 trials) and "Palonosetron" (1 trials). Other intervention names were less common.

The vast majority of trials in "NZOZ Magodent - Centrum Medczyne Ostrobramska" are 2 trials for "All" genders.

Currently, there are NaN active trials in "NZOZ Magodent - Centrum Medczyne Ostrobramska". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in NZOZ Magodent - Centrum Medczyne Ostrobramska, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in NZOZ Magodent - Centrum Medczyne Ostrobramska, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".